发明名称 NEW PROTEIN FORMULATION
摘要 <P>PROBLEM TO BE SOLVED: To provide a new and improved low-concentration formulation of an active enamel substance, such as an enamel matrix, enamel matrix derivative and/or an enamel matrix protein, intended to be used as a therapeutic, as a prophylactic and/or as a cosmetic agent. <P>SOLUTION: The active enamel substance can be incorporated into a polymeric matrix, which is either suitable for cellular in-growth, or cell-occlusive. The active enamel substance can be incorporated into the polymeric matrix so that it is released by degradation of the polymeric matrix, by enzymatic action and/or by diffusion. Thus in particular, a new pharmaceutical and/or cosmetic formulation of an active enamel substance at lower total concentration within the formulation is included and a spatial and/or selective regulation of release of the active enamel substance permits a greater percentage of the active enamel substance to be released at the time of appropriate cellular activity. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2011219492(A) 申请公布日期 2011.11.04
申请号 JP20110150581 申请日期 2011.07.07
申请人 STRAUMANN HOLDING AG 发明人 LYNGSTADAAS S PETTER;MOLENBERG AALDERT
分类号 A61K45/00;A61K;A61K6/08;A61K38/17;A61K47/34;A61K47/36;A61K47/42;A61K47/48;A61P1/02;A61P17/00;A61P19/04;A61P19/08;A61P29/00;A61P31/00;A61Q90/00 主分类号 A61K45/00
代理机构 代理人
主权项
地址